Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mina Nikanjam

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Clinical Pharmacology and Therapeutics|September 1, 2020
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics ApproachJerry Li, Mina Nikanjam, Coleen K Cunningham, et al.
Genome Medicine|October 5, 2021
Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve studyJason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Nature Communications|August 16, 2017
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathwaysThuc M Le, Soumya Poddar, Joseph R Capri, et al.
Nature Communications|October 3, 2020
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategyShumei Kato, Ki Hwan Kim, Hyo Jeong Lim, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Clinical Pharmacology and Therapeutics|September 1, 2020
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics ApproachJerry Li, Mina Nikanjam, Coleen K Cunningham, et al.
Genome Medicine|October 5, 2021
Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve studyJason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Nature Communications|August 16, 2017
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathwaysThuc M Le, Soumya Poddar, Joseph R Capri, et al.
Nature Communications|October 3, 2020
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategyShumei Kato, Ki Hwan Kim, Hyo Jeong Lim, et al.
Pageof 7